Cancer Genetics Inc (NASDAQ:CGIX)

0.99
Delayed Data
As of 3:59pm ET
 -0.0017 / -0.17%
Today’s Change
0.82
Today|||52-Week Range
4.25
-46.49%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$25.9M

Company Description

Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomaker solutions, biorepository solutions, consulting, cytogenetics testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Contact Information

Cancer Genetics, Inc.
Meadows Office Complex
Rutherford New Jersey 07070
P:(201) 528-9200
Investor Relations:

Employees

Shareholders

Individual stakeholders17.32%
Other institutional15.71%
Mutual fund holders1.51%

Top Executives

John A. RobertsPresident & Chief Executive Officer
Narasimha MarellaVice President-Operations
Rita ShaknovichChief Medical Officer & Group Medical Director
Weiyi ChenDirector-Molecular Diagnostics
Pal Singh-KahlonCytogenetics Director